Cargando…

The Epidemiology of COVID-19 in Malaysia

BACKGROUND: COVID-19 has rapidly spread across the globe. Critical to the control of COVID-19 is the characterisation of its epidemiology. Despite this, there has been a paucity of evidence from many parts of the world, including Malaysia. We aim to describe the epidemiology of COVID-19 in Malaysia...

Descripción completa

Detalles Bibliográficos
Autores principales: Jayaraj, Vivek Jason, Rampal, Sanjay, Ng, Chiu-Wan, Chong, Diane Woei Quan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529946/
https://www.ncbi.nlm.nih.gov/pubmed/34704083
http://dx.doi.org/10.1016/j.lanwpc.2021.100295
_version_ 1784586570792173568
author Jayaraj, Vivek Jason
Rampal, Sanjay
Ng, Chiu-Wan
Chong, Diane Woei Quan
author_facet Jayaraj, Vivek Jason
Rampal, Sanjay
Ng, Chiu-Wan
Chong, Diane Woei Quan
author_sort Jayaraj, Vivek Jason
collection PubMed
description BACKGROUND: COVID-19 has rapidly spread across the globe. Critical to the control of COVID-19 is the characterisation of its epidemiology. Despite this, there has been a paucity of evidence from many parts of the world, including Malaysia. We aim to describe the epidemiology of COVID-19 in Malaysia to inform prevention and control policies better. METHODS: Malaysian COVID-19 data was extracted from 16 March 2020 up to 31 May 2021. We estimated the following epidemiological indicators: 7-day incidence rates, 7-day mortality rates, case fatality rates, test positive ratios, testing rates and the time-varying reproduction number (Rt). FINDINGS: Between 16 March 2020 and 31 May 2021, Malaysia has reported 571,901 cases and 2,796 deaths. Malaysia's average 7-day incidence rate was 26•6 reported infections per 100,000 population (95% CI: 17•8, 38•1). The average test positive ratio and testing rate were 4•3% (95% CI: 1•6, 10•2) and 0•8 tests per 1,000 population (95% CI: <0•1, 3•7), respectively. The case fatality rates (CFR) was 0•6% (95% CI: <0•1, 3•7). Among the 2,796 cases who died, 87•3% were ≥ 50 years. INTERPRETATION: The public health response was successful in the suppression of COVID-19 transmission or the first half of 2020. However, a state election and outbreaks in institutionalised populations have been the catalyst for more significant community propagation. This rising community transmission has continued in 2021, leading to increased incidence and strained healthcare systems. Calibrating NPI based on epidemiological indicators remain critical for us to live with the virus. (243 words) FUNDING: This study is part of the COVID-19 Epidemiological Analysis and Strategies (CEASe) Project with funding from the Ministry of Science, Technology and Innovation (UM.0000245/HGA.GV).
format Online
Article
Text
id pubmed-8529946
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-85299462021-10-22 The Epidemiology of COVID-19 in Malaysia Jayaraj, Vivek Jason Rampal, Sanjay Ng, Chiu-Wan Chong, Diane Woei Quan Lancet Reg Health West Pac Research Paper BACKGROUND: COVID-19 has rapidly spread across the globe. Critical to the control of COVID-19 is the characterisation of its epidemiology. Despite this, there has been a paucity of evidence from many parts of the world, including Malaysia. We aim to describe the epidemiology of COVID-19 in Malaysia to inform prevention and control policies better. METHODS: Malaysian COVID-19 data was extracted from 16 March 2020 up to 31 May 2021. We estimated the following epidemiological indicators: 7-day incidence rates, 7-day mortality rates, case fatality rates, test positive ratios, testing rates and the time-varying reproduction number (Rt). FINDINGS: Between 16 March 2020 and 31 May 2021, Malaysia has reported 571,901 cases and 2,796 deaths. Malaysia's average 7-day incidence rate was 26•6 reported infections per 100,000 population (95% CI: 17•8, 38•1). The average test positive ratio and testing rate were 4•3% (95% CI: 1•6, 10•2) and 0•8 tests per 1,000 population (95% CI: <0•1, 3•7), respectively. The case fatality rates (CFR) was 0•6% (95% CI: <0•1, 3•7). Among the 2,796 cases who died, 87•3% were ≥ 50 years. INTERPRETATION: The public health response was successful in the suppression of COVID-19 transmission or the first half of 2020. However, a state election and outbreaks in institutionalised populations have been the catalyst for more significant community propagation. This rising community transmission has continued in 2021, leading to increased incidence and strained healthcare systems. Calibrating NPI based on epidemiological indicators remain critical for us to live with the virus. (243 words) FUNDING: This study is part of the COVID-19 Epidemiological Analysis and Strategies (CEASe) Project with funding from the Ministry of Science, Technology and Innovation (UM.0000245/HGA.GV). Elsevier 2021-10-21 /pmc/articles/PMC8529946/ /pubmed/34704083 http://dx.doi.org/10.1016/j.lanwpc.2021.100295 Text en © 2021 The Authors. Published by Elsevier Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Paper
Jayaraj, Vivek Jason
Rampal, Sanjay
Ng, Chiu-Wan
Chong, Diane Woei Quan
The Epidemiology of COVID-19 in Malaysia
title The Epidemiology of COVID-19 in Malaysia
title_full The Epidemiology of COVID-19 in Malaysia
title_fullStr The Epidemiology of COVID-19 in Malaysia
title_full_unstemmed The Epidemiology of COVID-19 in Malaysia
title_short The Epidemiology of COVID-19 in Malaysia
title_sort epidemiology of covid-19 in malaysia
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529946/
https://www.ncbi.nlm.nih.gov/pubmed/34704083
http://dx.doi.org/10.1016/j.lanwpc.2021.100295
work_keys_str_mv AT jayarajvivekjason theepidemiologyofcovid19inmalaysia
AT rampalsanjay theepidemiologyofcovid19inmalaysia
AT ngchiuwan theepidemiologyofcovid19inmalaysia
AT chongdianewoeiquan theepidemiologyofcovid19inmalaysia
AT jayarajvivekjason epidemiologyofcovid19inmalaysia
AT rampalsanjay epidemiologyofcovid19inmalaysia
AT ngchiuwan epidemiologyofcovid19inmalaysia
AT chongdianewoeiquan epidemiologyofcovid19inmalaysia